NewJeans loses Ador court battle to leave agency
NewJeans Loses Court Battle to Leave Agency K-pop group NewJeans has lost their court battle against management agency Ador, according to the Korea Herald. The five-piece group soug…
Why Neon Signs Are Essential for Modern Business | NorthPennNow
Why Neon Signs Are Essential for Modern Business In a competitive marketplace, standing out is essential. Neon signs, particularly the mod…
Kruti Patel Goyal Named Next CEO of Etsy
Kruti Patel Goyal Named Next CEO of Etsy Kruti Patel Goyal has been named the next Chief Executive Officer of Etsy, Inc., the global onlin…
Intracameral Antibiotics Reduce Endophthalmitis Risk in Patients With Capsular Ruptures
Intracameral Antibiotics Reduce Endophthalmitis Risk in Patients With Capsular Ruptures Intracameral antibiotics significantly lower endop…
The Tech Symphony: AI's Crescendo and the Gadget Orchestra
The Tech Symphony: AI's Crescendo and the Gadget Orchestra In the great symphony of technology, AI is the violinist with a penchant for so…
CNN announces election night coverage plans, including All Access-only ‘livecast’
CNN Announces Election Night Coverage Plans CNN has announced its plans for covering the off-cycle 2025 election. CNN will …
Record Job Cuts at Amazon and UPS. AI and Reorganization Changing the Face of Logistics
Record Job Cuts at Amazon and UPS Amazon plans to lay off around 14,000 employees, aiming to streamline operations and reduce bureaucracy.…
Trump Goes Full Dictator With Bonkers Threat to Use Air Force and Navy in U.S. Cities
Trump's Authoritarian Threats Spark Criticism President Donald Trump has sparked widespread criticism with his latest threat to use the mi…
KRWQ Debuts as South Korea’s First Won-Pegged Stablecoin by IQ and Frax | HODL FM
KRWQ: South Korea's First Won-Pegged Stablecoin IQ and Frax, an AI-agent platform and a decentralized finance protocol, respectively, have…
‘Jesus, I surrender to you!’: A heart surgery patient’s journey - The Catholic Messenger
A Heart Surgery Patient's Journey By Diane Oetken VanDuzen, Guest Column I stepped out of the stuffy waiting room into the coolness…
A Closer Look at New FDA Guidance Removing Barriers to Biosimilar Development
A Closer Look at New FDA Guidance Removing Barriers to Biosimilar Development The FDA's new guidance streamlines biosimilar development, r…